You are here Biopharmaceutical/Genomics
Glossary
Homepage Contact Biopharmaceutical Glossaries &
Taxonomies
Contact
Cambridge Healthtech's Biopharmaceutical Glossaries & Taxonomies
Evolving Terminology for Emerging Technologies
Last revised
March 18, 2019
I'm always interested in hearing about new words or phrases
you've found, or ambiguous or unclear terms you run across. Your questions help me focus
on three critical priorities
1. What are up and coming concepts that may be
the" next big things"?
2. What are the incremental or interdisciplinary
changes that can make a big difference in day to day work in the lab, the
library or at the computer "in silico" work.
3. How are seemingly disparate
subject areas becoming connected, how can they be better integrated and can people communicate better?
These are exciting - if turbulent and uncertain times!
When I started this
project it seemed as if the web was the only way to keep up with such rapidly
changing concepts. But as I have worked on them since 1999 I have come to
realize that while I keep adding content, what is here doesn't become out of
date nearly as quickly as I expected, and a print version could be very
useful. I'm interested in finding a publisher and offer the Concise
Biopharmaceutical Glossary as a draft manuscript.
About Cambridge Healthtech
Institute (CHI) from the original 1992 company mission statement
Researchers and executives responsible for developments in any
given segment of biomedical research face the almost overwhelming task of trying
to keep up with important developments.
CHI was established to facilitate the discussion and exchange of technical and
commercialization information. Heavy emphasis is placed on new products
and technological advances still in the evaluation stage. Basic research
is covered, but within the context of implications of recent advances for the
development of new products and technologies.
CHI focuses on being a useful, timely
and effective supplement to specialized journals, newsletters, and other
meetings. Technologies in which rapid progress in applied research and a
variety of significant strategies are being explored are emphasized. Priority is
given to depth of coverage. Considerable attention is paid to identifying
promising, but less publicized research being carried out at smaller companies
and universities, both in the US and elsewhere, and to unique approaches that
are at an early evaluation stage, to give people valuable new insights and
competing points of view, along with balanced coverage of the latest
developments.
Cambridge Healthtech Institute (CHI)
is the life science network for
researchers and business experts from pharmaceutical, biotech and
academic organizations. CHI’s portfolio of products includes
Cambridge Healthtech Institute Conferences, Insight Pharma Reports,
Cambridge Marketing Consultants, Barnett International, Cambridge
Meeting Planners and Healthtech Publishing, which includes Bio-IT
World, Clinical Informatics News and Diagnostics World.
http://www.healthtech.com/
|